Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2012 /
Defining personalised medicine and patient empowerment

28th Sep - 2nd Oct 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.10.12
Views: 3416

Prof Gabriella Pravettoni – University of Milan, Italy

Prof Gabriella Pravettoni talks with ecancer at the 2012 ESMO meeting in Vienna about the need in personalised medicine to concentrate on the patient receiving treatment and not only genomics. 


Prof Pravettoni defines personalised medicine as helping the individual immediately, for example, with tools to help with follow up, communication with doctors and understanding treatment options. She also discusses her recent reply to a Nature article that, she feels, left out the most important part of personalised medicine, P5 or the individual.


Personalised medicine and patient profiles also allow for the better understanding of potential candidates for clinical trials.


Filming supported by Amgen

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation